Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease Potential for Targeting Inflammation With Canakinumab

被引：12
作者：
Cherney, David Z. I. [1 ,2 ]
Lytvyn, Yuliya [1 ,2 ]
McCullough, Peter A. [3 ]
机构：
[1] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[3] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 21期
关键词：
canakinumab; cardiovascular risk; CKD; inflammation; C-REACTIVE PROTEIN; INTERLEUKIN-1-BETA INHIBITION;
D O I：
10.1016/j.jacc.2018.04.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2415 / 2418
页数：4
相关论文
共 50 条
  • [31] Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Risk in Patients with Chronic Kidney Disease without Previous Cardiac Pathology
    Kislikova, Maria
    Lopez, Maria Ana Batlle
    Salinas, Francisco Javier Freire
    Blanco, Jose Antonio Parra
    Molina, Maria Pilar Garcia-Berbel
    Fernandez, Alejandro Aguilera
    Haces, Vicente Celestino Pinera
    Unzueta, Maria Teresa Garcia
    Hernandez, Adalberto Benito
    Millan, Juan Carlos Ruiz San
    Rodrigo Calabia, Emilio
    LIFE-BASEL, 2023, 13 (09):
  • [32] Periodontal inflammation in patients with chronic kidney disease
    Dipalma, G.
    Inchingolo, A. D.
    Mancini, A.
    Maggiore, M. E.
    Tartaglia, G. M.
    Malcangi, G.
    Semjonova, A.
    Del Prete, R.
    Ferrara, E.
    Lorusso, F.
    Scarano, A.
    Ferati, K.
    Signorile, G. S.
    Clemente, A.
    Tesoro, I.
    Gnoni, A.
    Scacco, S.
    Rapone, B.
    Inchingolo, A. M.
    Inchingolo, F.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (02) : 41 - 50
  • [33] The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease
    Verbeke, Francis
    Siwy, Justyna
    Van Biesen, Wim
    Mischak, Harald
    Pletinck, Anneleen
    Schepers, Eva
    Neirynck, Nathalie
    Magalhaes, Pedro
    Pejchinovski, Martin
    Pontillo, Claudia
    Lichtinghagen, Ralf
    Brand, Korbinian
    Vlahou, Antonia
    De Bacquer, Dirk
    Glorieux, Griet
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (05) : 811 - 818
  • [34] Use of Aspirin and Initial Cardiovascular and Bleeding Risk in Patients with Chronic Kidney Disease
    Kim, Jae Young
    Lim, Hyunsun
    Park, Cheol Ho
    Kim, Hyung Woo
    Chang, Tae Ik
    Han, Seung Hyeok
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 20 (03): : 387 - 396
  • [35] Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer
    Provenzano, Michele
    Coppolino, Giuseppe
    Faga, Teresa
    Garofalo, Carlo
    Serra, Raffaele
    Andreucci, Michele
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2019, 20 (04) : 209 - 220
  • [36] Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease
    Hung, Szu-Chun
    Kuo, Ko-Lin
    Peng, Ching-Hsiu
    Wu, Che-Hsiung
    Lien, Yu-Chung
    Wang, Yi-Chun
    Tarng, Der-Cherng
    KIDNEY INTERNATIONAL, 2014, 85 (03) : 703 - 709
  • [37] Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease
    Baaten, Constance C. F. M. J.
    Vondenhoff, Sonja
    Noels, Heidi
    CIRCULATION RESEARCH, 2023, 132 (08) : 970 - 992
  • [38] Cardiovascular Risk in Patients with Chronic Kidney Disease with Special Reference to Statin Therapy
    Tomoyuki Kawada
    High Blood Pressure & Cardiovascular Prevention, 2022, 29 : 625 - 626
  • [39] Cardiovascular Risk in Patients with Chronic Kidney Disease with Special Reference to Statin Therapy
    Kawada, Tomoyuki
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (06) : 625 - 626
  • [40] Gut-immune axis and cardiovascular risk in chronic kidney disease
    Behrens, Felix
    Bartolomaeus, Hendrik
    Wilck, Nicola
    Holle, Johannes
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
12345